Pharmacy

OpenAI's GPT-4 and Google's Gemini did not recommend opioid medication for one group over another – suggesting that artificial intelligence could help address clinician bias and improve fairness in treating pain.

AlphaProteo was created to advance drug design and disease understanding by helping researchers configure high-strength proteins that bind to molecules.

Anne Moen of Gravitate-Health says the company wants to work with regulators to help European patients translate prescription information into their language of choice while traveling through the EU.

QuantHealth helps pharma implement artificial intelligence for drug development using clinical trial simulation. Orr Inbar, its cofounder and CEO, discusses that — and the long-term effects of AI on drug development.

Also: Pfizer says it is partnering with healthcare organizations to develop a new digital health platform that provides access to same-day care, prescriptions and vaccines for COVID-19 or the flu.

This follows recent integrations of e-prescriptions and real-time prescription monitoring into its EHR.

CMS said that if the new prices had been in effect last year, Medicare would have saved an estimated $6 billion across the 10 drugs.

Also, the Korean government is investing $25 million in developing AI for drug discovery.

Offered in partnership with Novo Nordisk Foundation, the fellowship will focus on technologies that analyze vast amounts of data to increase diagnostic accuracy, speed personalized medicine and improve clinical trials.

If artificial intelligence can do good for struggling patients and help them avoid crippling medical debt, half of the Americans said they are in.